Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant

Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant

US Patent 10441653 · Granted Oct 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of vaccination and inhibition of the PD-1 pathway2025
Dry powder composition comprising long-chain RNA2025
RNA encoding a therapeutic protein2025
Method for producing and purifying RNA, comprising at least one step of tangenti2025
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence2025
Lyophilization of RNA2025
Dry powder composition comprising long-chain RNA2024
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence2024
Composition for treating prostate cancer (PCa)2024
Composition for treating prostate cancer (PCa)2024
Method for producing and purifying RNA, comprising at least one step of tangenti2023
Method for producing and purifying RNA, comprising at least one step of tangenti2023